home / stock / vm:cc / vm:cc news

VM:CC News and Press, Voyageur Pharmaceuticals Ltd. From 06/23/25

Stock Information
Company Name: Voyageur Pharmaceuticals Ltd.
Stock Symbol: VM:CC
Market: TSXVC
Website: voyageurpharmaceuticals.ca
Menu
VM:CC VM:CC Quote VM:CC Short VM:CC News VM:CC Articles VM:CC Message Board
Get VM:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
VM:CC - Voyageur and Altillion Forge Landmark Alliance to Establish North America's First Vertically Integrated Iodine Drug Supply Chain

(TheNewswire) Calgary, Alberta – TheNewswire - June 23, 2025 – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (“Voyageur” or the “Company”), a Canadian public company developing cost-effective imaging contrast media, is pleased to annou...
VM:CC - Voyageur Enters Revenue Stage with First Commercial Sale of Barium Contrast Agents

(TheNewswire) Calgary, Alberta, Canada – TheNewswire - June 4, 2025 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company"), a radiology contrast media company focused on vertical integration and supply chain security, today announced its fir...

VM:CC - Voyageur Pharmaceuticals Announces Appointment of Ethan Mohan as Executive Vice President

(TheNewswire) Calgary, Alberta, Canada – May 12, 2025 – TheNewswire - Voyageur Pharmaceuticals Ltd. ( TSX.V:VM ) ( OTC Pink:VYYRF ) (" Voyageur " or the " Company ") a radiology contrast media company focused on vertical integration and ...

VM:CC - Voyageur Pharmaceuticals Announces Changes to Board of Directors and DSU Grant

(TheNewswire) FOR IMMEDIATE RELEASE Ralph Hesje Retires as Chairman Eric Pommer Assumes Role of Chairperson Beth Shaw Appointed to Board CALGARY, AB – TheNewswire - May 1, 2025 – Voyageur Pharmaceuticals Ltd. (the " C...
VM:CC - Voyageur Launches Market Introduction of Barium Contrast Product Line Following Successful Clinical Study Results

(TheNewswire) Positive feedback received after completion of CDC tests on 24 subjects All key product performance milestones met or exceeded expectations Well positioned to compete with international counterparts in qualified jurisdictions Advancing t...

VM:CC - Voyageur Completes Human Testing of Barium Contrast Products and Prepares for Canadian Market Launch

(TheNewswire) Calgary, Alberta, Canada – April 1, 2025 – TheNewswire - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (" Voyageur " or the " Company ") is pleased to announce the successful completion of a key phase in human testi...

VM:CC - Voyageur Pharmaceuticals Advances Frances Creek Project, Paving the Way for a Secure, Vertically Integrated Barium Contrast Product Line

(TheNewswire) Calgary, Alberta, Canada – March 4, 2025 – TheNewswire - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“ Voyageur ” or the “ Company ”) is pleased to announce the commencement of the Frances...
VM:CC - Voyageur Clarifies Terms of Previously Announced Agreement

Calgary, Alberta--(Newsfile Corp. - March 3, 2025) - Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) ("Voyageur" or the "Company") wishes to clarify the terms of a distribution and wholesaling agreement (the " Agreement ") it previously announced on May 28, 2024, and referred to subseq...

VM:CC - Voyageur Advances MRI Drug Development Using Next Generation Endohedral Fullerenes

(TheNewswire) Calgary, Alberta, Canada – February 18, 2025 – TheNewswire - Voyageur Pharmaceuticals Ltd. ( TSX.V:VM ) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce the launch of its next generation MRI contrast agent development ...

VM:CC - Voyageur Receives $600K Grant from Alberta Innovates for Product Development

(TheNewswire) Voyageur receives $600,000 in funding through Alberta Innovates AICE-Market Access Program Calgary, Alberta, Canada – February 5, 2025 – TheNewswire - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“ Voyageur &#x...
Previous 10 Next 10